wide
varieti
virus
exploit
furin
proprotein
convertas
pc
constitut
protein
secret
pathway
order
regul
cell
entri
mechan
infect
regul
viral
cell
entri
proteas
control
mechan
common
among
virus
tabl
proteolyt
process
viral
protein
often
requir
viru
matur
infect
critic
group
hostcel
proteas
exploit
varieti
virus
famili
proprotein
convertas
pc
includ
furin
although
type
proteas
besid
pc
also
perform
proteolyt
matur
virus
observ
pc
process
viral
protein
virus
becom
compar
infect
pathogen
research
done
matur
virus
pc
focus
furin
howev
evid
involv
pc
regul
viru
matur
scatter
inform
role
pc
life
cycl
wide
varieti
virus
addit
new
develop
pc
activ
regul
reaction
specif
call
effort
integr
knowledg
analyz
relev
pc
pathogen
virus
evalu
feasibl
inhibit
pc
sound
strategi
antivir
therapi
review
discuss
import
differ
pc
reactiv
select
pc
gene
express
profil
infect
cell
determin
viru
infect
tropism
proteolyt
matur
virus
pc
gener
involv
process
protein
local
surfac
viral
particl
either
nonenvelop
envelop
virus
cleavag
surfac
viral
protein
mostli
occur
insid
host
cell
viru
morphogenesi
egress
although
cleavag
targetcel
pc
occur
extracellularli
cell
entri
virus
proteolyt
process
pc
promot
bind
fusion
viral
particl
target
cell
pc
eukaryot
serin
proteas
classifi
merop
peptidas
databas
within
famili
furin
part
kexinlik
subfamili
pc
local
organel
constitut
protein
secret
pathway
pc
perform
proteolyt
posttransl
modif
larg
varieti
peptid
protein
transgolgi
network
endosom
pericellular
environ
critic
regul
central
cellular
process
growth
prolifer
differenti
gene
express
profil
kexinlik
pc
celltyp
depend
cell
express
except
whose
express
restrict
cell
type
test
ovari
placenta
pc
larges
multidomain
protein
compos
conserv
catalyt
regulatori
p
domain
share
amino
acid
sequenc
homolog
figur
furin
type
membranebound
protein
furin
pc
eukaryot
serin
proteas
classifi
merop
peptidas
databas
within
famili
furin
part
kexinlik
subfamili
pc
local
organel
constitut
protein
secret
pathway
pc
perform
proteolyt
posttransl
modif
larg
varieti
peptid
protein
transgolgi
network
endosom
pericellular
environ
critic
regul
central
cellular
process
growth
prolifer
differenti
gene
express
profil
kexinlik
pc
celltyp
depend
cell
express
except
whose
express
restrict
cell
type
test
ovari
placenta
pc
larges
multidomain
protein
compos
conserv
catalyt
regulatori
p
domain
share
amino
acid
sequenc
homolog
figur
furin
type
membranebound
protein
furin
shed
extracellularli
contrast
secret
protein
kexinlik
pc
cleav
substrat
site
specifi
motif
compos
x
x
amino
acid
residu
cleavag
occur
x
residu
sequenc
motif
found
mani
viral
surfac
protein
determin
cleavag
pc
kexinlik
pc
divid
two
specif
group
one
repres
furin
furin
virus
reactiv
pc
differ
reaction
specif
two
group
base
activesit
exosit
determin
reactiv
kexinlik
pc
consid
potenti
pharmacolog
target
treatment
viral
infect
block
viru
matur
infect
use
target
pc
includ
inhibit
activ
bacteri
toxin
shiga
anthrax
clostridium
pseudomona
diphtheria
also
treatment
degen
diseas
metastat
cancer
alzheim
osteoarthr
known
natur
inhibitor
pc
serpin
slowbind
type
inhibitor
form
covalentlylink
inhibitori
complex
target
proteas
serpin
current
pc
inhibitori
serpin
identifi
vertebr
higher
specif
furin
pc
inhibitori
serpin
character
organ
well
varieti
synthet
pc
inhibitor
develop
base
small
molecul
peptid
mimet
deriv
larger
protein
howev
main
obstacl
therapeut
use
toxic
lack
pc
select
import
research
tool
pc
inhibitor
deriv
serpin
engin
pc
cleavag
site
motif
reactiv
loop
engin
serpin
inhibit
kexinlik
pc
specif
recent
develop
two
chimera
select
target
two
pc
specif
group
one
specif
inhibit
furin
specif
inhibit
literatur
proteolyt
process
viral
surfac
protein
pc
role
pc
play
matur
virus
review
final
develop
pc
inhibitor
antivir
properti
discuss
human
papillomaviru
hpv
infect
basal
cell
stratifi
epithelium
virion
replic
depend
infect
basal
cell
progress
differenti
squamou
cell
hpv
infect
reach
lower
layer
stratifi
epithelium
microwound
tissu
viral
particl
bind
heparin
sulfat
proteoglycan
receptor
local
either
extracellular
matrix
basement
membran
cell
surfac
hpv
particl
constitut
nake
nucleocapsid
work
done
pseudovirion
particl
suggest
conform
chang
nucleocapsid
protein
induc
upon
bind
viru
cellsurfac
proteoglycan
prime
cleavag
extracellular
pericellular
pc
residu
cleavag
modifi
conform
coat
protein
allow
virion
engag
anoth
receptor
lead
cell
intern
infect
inhibit
targetcel
pc
block
hpv
infect
treatment
pseudovirion
particl
furin
beforehand
bypass
inhibit
contrast
cleavag
live
nativ
virion
pc
occur
virion
morphogenesi
infect
becom
independ
targetcel
pc
also
proteolyt
process
seem
hpvtype
depend
evidenc
nativ
virion
poorli
process
morphogenesi
infect
mostli
depend
pc
target
cell
contain
pc
cleavag
site
motif
besid
commonli
studi
two
pc
cleavag
site
motif
one
conserv
mani
hpv
type
tabl
mutagenesi
site
report
affect
pseudovirion
morphogenesi
site
locat
region
involv
regul
retrograd
traffick
genom
complex
transgolgi
network
nucleu
surprisingli
lowrisk
hpv
type
ly
posit
instead
arg
highrisk
type
tabl
cleavag
site
requir
viru
morphogenesi
lowand
highrisk
type
may
use
differ
proteas
unless
morphogenesi
differ
cleavag
site
take
place
cell
entri
cleavag
site
may
hidden
insid
fold
protein
protect
access
pc
intact
virion
howev
virion
undergo
control
unfold
entri
traffick
pc
cleavag
site
may
becom
expos
cleav
along
cell
intern
rout
potenti
divers
express
pc
gene
keratinocyt
differ
anatom
site
hpv
infect
may
contribut
restrict
cell
tropism
hpv
type
especi
differ
skin
mucos
type
commonli
found
stratifi
epithelium
ectocervix
tonsilar
crypt
mainli
found
glandular
epithelium
endocervix
differ
pc
reactiv
may
play
role
determin
particular
tropism
tabl
pc
cleavag
site
motif
coat
protein
hpv
type
cleavag
site
number
correspond
sequenc
residu
denot
red
envelop
glycoprotein
b
gb
conserv
protein
among
herp
virus
function
regul
viru
cell
membran
fusion
gb
synthes
precursor
protein
pc
cleav
loop
locat
domain
ii
ectodomain
distanc
fusion
loop
domain
cleavag
site
loop
highli
variabl
length
amino
acid
sequenc
among
herp
virus
tabl
cleavag
gb
pc
demonstr
herp
virus
least
one
pc
cleavag
site
motif
cleavag
loop
although
except
pc
motif
contrast
virus
one
pc
cleavag
site
may
cleav
sequenti
experiment
inactiv
pc
cleavag
site
sever
herp
virus
sever
affect
viral
cell
entri
cell
grow
vitro
howev
lack
pc
cleavag
reduc
viru
spread
replic
vivo
cleavag
gb
promot
virustocel
celltocel
fusion
although
much
still
need
consolid
knowledg
cleavag
gb
pc
doubt
presenc
pc
cleavag
site
motif
gb
result
select
evolutionari
pressur
two
protein
predomin
envelop
flavivirus
prm
glycoprotein
e
associ
two
protein
prme
immatur
viru
chang
upon
cleavag
prm
pc
egress
pr
segment
remov
render
matur
virion
flavivirus
contain
pc
cleavag
site
motif
prm
junction
tabl
peculiar
case
matur
dengu
viru
denv
proteolyt
process
known
ineffici
virion
produc
prme
form
high
proport
initi
suspect
matur
might
necessari
infect
later
demonstr
inde
need
ineffici
matur
denv
agre
studi
show
antiprm
antibodi
repres
signific
proport
immun
respons
denv
antibodi
respons
develop
antibodydepend
enhanc
ade
infect
individu
suffer
recurr
denv
infect
observ
suggest
denv
pc
reactiv
weaker
compar
flavivirus
seem
matur
effici
pc
site
sequenc
align
present
tabl
show
four
denv
type
asp
glu
residu
posit
cleavag
site
compar
ser
thr
flaviviru
sequenc
includ
zika
viru
zikv
acid
residu
posit
substrat
sequenc
detriment
reactiv
pc
base
differ
expect
denv
react
dramat
lower
reactiv
toward
pc
compar
flavivirus
higher
rate
pc
reactiv
align
strong
virul
broad
cell
tropism
observ
flavivirus
therefor
surpris
zikv
even
reach
fetu
remain
bodili
fluid
asymptomat
patient
extend
period
compar
denv
variat
pc
gene
express
profil
may
key
factor
determin
differ
tropism
test
zikv
denv
primari
pc
express
test
vigor
reactiv
zikv
would
explain
test
suffer
highest
load
zikv
compar
organ
sexual
transmiss
viru
viral
pc
reactiv
cell
pc
gene
express
profil
probabl
play
role
determin
cell
tropism
differ
observ
flavivirus
virus
genu
alphaviru
like
chikungunya
chikv
semliki
forest
sfv
sindbi
ross
river
arbovirus
structur
relat
flavivirus
glycoprotein
precursor
cleav
pc
order
regul
interact
glycoprotein
promot
viru
cell
fusion
infect
inform
avail
process
togaviru
protein
pc
scant
reveal
exist
amino
acid
sequenc
variabl
pc
cleavag
site
chikv
asian
african
strain
variabl
probabl
determin
observ
differ
pc
select
famili
coronavirus
includ
virus
relev
human
veterinari
health
like
envelop
virus
reli
surfac
glycoprotein
bind
fusion
coronavirus
spike
protein
cleav
proteas
virion
biosynthesi
well
entri
target
cell
proteolyt
regul
coronavirus
probabl
one
beststudi
system
complet
pictur
regulatori
system
mechan
develop
compar
famili
virus
less
wellstudi
gener
principl
proteolyt
regulatori
mechan
coronavirus
base
accumul
evid
includ
virus
regul
varieti
proteas
protein
cleav
sequenti
two
cleavag
site
virus
quickli
adapt
proteolyt
environ
infect
cell
compat
cleavag
sitespecif
cell
proteas
express
profil
determin
cell
tissu
tropism
pathogen
viru
furin
proteas
regul
function
coronaviru
fusion
protein
proteas
membranebound
tmprss
lysosom
cathepsin
elastas
coagul
factor
xa
also
implic
protein
cleav
junction
biosynthesi
separ
two
major
domain
protein
domain
involv
receptor
bind
domain
mediat
fusion
step
cell
entri
mechan
cell
entri
cleavag
prime
second
cleavag
site
mani
coronavirus
cleavag
seem
dispens
howev
cleavag
cleavag
suggest
serv
virul
marker
predict
furinpc
reactiv
base
amino
acid
sequenc
surround
cleavag
site
made
base
comput
algorithm
howev
depend
furinpc
reactiv
conform
substrat
exosit
lend
uncertainti
predict
highli
virul
merscov
middl
east
respiratori
syndrom
coronaviru
natur
viru
known
pc
cleavag
site
motif
site
virus
two
pc
site
result
laboratori
select
serial
passag
cell
line
vitro
one
viru
infecti
bronchiti
viru
ibvbeaudett
strain
merscov
expand
tropism
compar
coronavirus
consid
polytrop
site
sarscov
sever
acut
respiratori
syndrom
coronaviru
pc
cleavag
site
motif
fact
merscov
sarscov
highli
pathogen
ibvbeaudett
apathogen
line
virus
react
proteas
pc
promot
sarscov
merscov
infect
vivo
engin
pc
specif
cleavag
site
coronaviru
protein
modifi
viru
tropism
virul
convers
monobas
cleavag
site
polybas
site
make
viru
suscept
pc
cleavag
also
increas
chanc
cleavag
proteas
target
singl
arginin
residu
surpris
merscov
pathogen
coronavirus
adapt
differ
proteolyt
environ
mani
cell
type
infect
viru
may
activ
specif
set
proteas
crucial
defin
proteas
cleavag
specif
virus
impact
human
anim
health
use
pc
inhibitor
decrvkrcmk
creat
controversi
sometim
inhibitor
use
excess
concentr
inhibitor
bind
pc
high
affin
low
nm
concentr
slowli
form
coval
complex
enzym
inhibit
pc
stoichiometr
manner
hand
treat
cell
inhibitor
concentr
enough
block
cell
entri
complet
concentr
report
studi
consid
pcspecif
high
inhibitor
concentr
probabl
inhibit
proteas
besid
pc
medic
relev
retrovirus
retrovirida
famili
also
studi
concern
proteolyt
regul
studi
virus
bovin
murin
leukemia
virus
relat
human
tlymphotrop
virus
envelop
glycoprotein
cleav
furin
pc
like
coronavirus
leukemia
viru
glycoprotein
cleav
twice
pc
perform
first
cleavag
induc
conform
chang
disulfid
isomer
prime
protein
proteolysi
second
proteolyt
event
perform
viral
proteas
fulli
activ
glycoprotein
human
immunodefici
viru
hiv
env
glycoprotein
precursor
cleav
furin
biosynthesi
transgolgi
network
figur
process
furin
leav
tgn
env
glycoprotein
antigen
hiv
protein
furin
cleavageindepend
form
stabil
nativ
form
produc
vaccin
develop
purpos
interestingli
polybas
region
locat
upstream
pc
cleavag
site
junction
shown
bind
heparin
promot
cleavag
medic
relev
retrovirus
retrovirida
famili
also
studi
concern
proteolyt
regul
studi
virus
bovin
murin
leukemia
virus
relat
human
tlymphotrop
virus
envelop
glycoprotein
cleav
furin
pc
like
coronavirus
leukemia
viru
glycoprotein
cleav
twice
pc
perform
first
cleavag
induc
conform
chang
disulfid
isomer
prime
protein
proteolysi
second
proteolyt
event
perform
viral
proteas
fulli
activ
glycoprotein
human
immunodefici
viru
hiv
env
glycoprotein
precursor
cleav
furin
biosynthesi
transgolgi
network
figur
process
furin
leav
tgn
env
glycoprotein
antigen
hiv
protein
furin
cleavageindepend
form
stabil
nativ
form
produc
vaccin
develop
purpos
interestingli
polybas
region
locat
upstream
pc
cleavag
site
junction
shown
bind
heparin
promot
cleavag
figur
xray
crystal
structur
envelop
glycoprotein
monom
fusion
machin
compos
three
monom
divid
ntermin
green
ctermin
gray
residu
red
denot
end
residu
blue
begin
pc
cleavag
pdb
id
code
duck
hepat
b
viru
dhbv
use
model
studi
hepat
b
viru
hbv
proteolyt
event
regul
cell
entri
mechan
hepadnaviru
attract
much
attent
evid
cleavag
envelop
protein
pc
singlestrand
negativesens
rna
virus
filovirida
arenavirida
famili
neword
bunyaviral
caus
agent
lethal
hemorrhag
fever
diseas
despit
serious
health
threat
virus
repres
inform
proteolyt
regul
entri
mechan
scarc
envelop
glycoprotein
ebola
ebov
marburg
mbgv
virus
process
furin
two
disulfidelink
subunit
except
reston
strain
pc
cleavag
site
motif
ebov
strain
one
reston
strain
less
pathogen
ebov
strain
figur
xray
crystal
structur
envelop
glycoprotein
monom
fusion
machin
compos
three
monom
divid
ntermin
green
ctermin
gray
residu
red
denot
end
residu
blue
begin
pc
cleavag
pdb
id
code
duck
hepat
b
viru
dhbv
use
model
studi
hepat
b
viru
hbv
proteolyt
event
regul
cell
entri
mechan
hepadnaviru
attract
much
attent
evid
cleavag
envelop
protein
pc
singlestrand
negativesens
rna
virus
filovirida
arenavirida
famili
neword
bunyaviral
caus
agent
lethal
hemorrhag
fever
diseas
despit
serious
health
threat
virus
repres
inform
proteolyt
regul
entri
mechan
scarc
envelop
glycoprotein
ebola
ebov
marburg
mbgv
virus
process
furin
two
disulfidelink
subunit
except
reston
strain
pc
cleavag
site
motif
ebov
strain
one
reston
strain
less
pathogen
ebov
strain
glycoprotein
mbgv
two
pc
cleavag
site
motif
agre
amino
acid
sequenc
posit
compar
singl
pc
site
ebov
protein
cleavag
furin
seem
dispens
elimin
pc
site
ebov
protein
affect
viru
replic
cultur
cell
diseas
progress
experiment
anim
ebov
requir
proteolyt
process
glycoprotein
bind
domain
endosom
cathepsin
order
gain
bind
activ
filovirus
differ
virus
requir
addit
factor
modif
glycoprotein
order
gain
infect
crimeancongo
hemorrhag
fever
bunyaviru
cchfv
glycoprotein
process
furin
proprotein
convertas
pc
pyrolysinlik
type
also
known
cleavag
site
specif
differ
polybas
specif
kexinlik
pc
cleavag
furin
essenti
inactiv
cleavag
site
slow
viru
replic
lymphocyt
choriomening
lcmv
lassa
lasv
arenavirus
known
also
requir
activ
cleavag
envelop
glycoprotein
paramyxovirida
divers
famili
virus
varieti
proteas
activ
fusion
protein
paramyxovirus
highli
pathogen
singl
proteolyt
process
fusion
protein
occur
virus
pc
perform
cleavag
parainfluenza
measl
mv
virus
sever
serotyp
avian
paramyxovirus
apmv
glycoprotein
highli
pathogen
newcastl
diseas
viru
ndv
cleav
furin
protein
serotyp
cleav
undetermin
trypsinlik
proteas
mutat
trypsinlik
site
pc
site
motif
made
virus
replic
faster
cell
cultur
remain
nonvirul
vivo
convers
transform
pc
cleavag
site
virul
strain
trypsinlik
site
induc
viru
becom
highli
attenu
pathogen
respiratori
syncyti
viru
rsv
uniqu
among
paramyxovirus
glycoprotein
cleav
two
site
pc
first
cleavag
take
place
viru
enter
target
cell
second
occur
entri
endosom
furin
activ
lethal
nipah
niv
hendra
hev
virus
entri
instead
virus
depend
endosom
cathepsin
virus
produc
system
infect
sever
differ
host
glycoprotein
sendai
viru
sev
requir
particip
homolog
attach
protein
hemagglutininneuraminidas
hn
bind
cell
surfac
sialic
acid
receptor
sev
glycoprotein
one
trypsinlik
site
replac
two
rsv
pc
site
depend
hn
infect
reduc
influenza
virus
caus
respiratori
diseas
occasion
pandem
viru
envelop
contain
two
glycoprotein
hemagglutinin
ha
neuraminidas
na
protein
contribut
viru
pathogen
cleavag
ha
precursor
ha
ha
host
cell
pc
signific
contributor
virul
avian
influenza
figur
extent
divers
cellular
proteolyt
activ
also
essenti
factor
determin
pathogen
spread
tropism
influenza
viru
ha
type
commonli
present
type
season
human
infect
type
found
bird
pandem
caus
strain
respect
proteolyt
cleavag
ha
occur
loop
vari
length
amino
acid
sequenc
depend
strain
tabl
loop
usual
contain
one
arg
residu
determin
cleavag
trypsinlik
proteas
cleavag
occur
synthesi
releas
entri
may
depend
differ
proteas
highli
pathogen
viru
strain
respons
spanish
influenza
pandem
type
one
arg
residu
cleavag
loop
two
proteas
highli
express
respiratori
tract
especi
lung
shown
cleav
influenza
ha
hat
proteas
express
airway
mostli
larynx
lung
also
capabl
activ
influenza
virus
multibas
cleavag
site
ha
aris
singl
substitut
mutat
like
case
type
insert
result
longer
loop
observ
highli
pathogen
type
virus
acquir
multibas
cleavag
site
becom
independ
trypsinlik
proteas
lowpathogen
strain
carri
cleavag
site
motif
rskr
cleavag
perform
pc
matriptas
recogn
cleavag
site
motif
pc
determin
nephrotrop
viru
howev
becom
reactiv
pc
remov
glycosyl
site
near
cleavag
site
long
multibas
loop
strain
highli
reactiv
furin
reactiv
lead
high
pathogen
caus
system
infect
outbreak
highli
pathogen
avian
strain
infect
human
occur
hong
kong
highli
pathogen
type
kkkr
motif
cleavag
carri
ubiquit
proteas
mspl
splice
variant
also
capabl
cleav
pc
cleavag
site
motif
tabl
cleavag
loop
ha
protein
influenza
virus
variabl
region
blue
arrow
denot
cleavag
site
residu
color
red
figur
xray
crystal
structur
ha
trimer
influenza
viru
type
ha
monom
divid
red
blue
gray
oarang
cyan
white
respect
subunit
pc
cleavag
denot
residu
end
yellow
begin
purpl
pdb
id
code
multibas
cleavag
site
ha
aris
singl
substitut
mutat
like
case
type
insert
result
longer
loop
observ
highli
pathogen
type
virus
acquir
multibas
cleavag
site
becom
independ
trypsinlik
proteas
lowpathogen
strain
carri
cleavag
site
motif
rskr
cleavag
perform
pc
matriptas
figur
xray
crystal
structur
ha
trimer
influenza
viru
type
ha
monom
divid
ha
red
blue
gray
ha
oarang
cyan
white
respect
subunit
pc
cleavag
denot
residu
end
ha
yellow
begin
ha
purpl
pdb
id
code
search
effect
pc
inhibitor
center
find
inhibitor
best
characterist
specif
stabil
bioavail
pc
inhibitor
report
develop
furin
although
inhibitor
high
pc
specif
mani
still
lack
proper
character
pc
select
know
pc
select
inhibitor
critic
issu
pc
differ
substrat
specif
virus
pcselect
synthet
pc
inhibitor
come
sever
form
small
molecul
identifi
highthroughput
screen
peptid
substrat
viral
cleavag
site
peptid
mimet
deriv
add
unnatur
amino
acid
cyclic
peptid
polyarginin
larger
engin
protein
like
leech
eglin
c
turkey
ovomucoid
engin
serpin
peptid
deriv
seem
effici
produc
highaffin
pc
inhibitor
compar
small
molecul
due
high
densiti
neg
charg
pc
activ
site
highli
basic
peptid
show
strong
specif
bioavail
may
also
highli
toxic
larger
protein
pois
becom
effect
pc
inhibitor
offer
better
opportun
build
specif
select
compar
small
molecul
also
made
bioavail
varieti
rout
sever
pc
inhibitor
confirm
antivir
activ
cellbas
assay
viral
propag
tabl
tabl
inhibitor
pc
test
antivir
activ
cellbas
assay
viral
propag
inhibitor
lcmv
lasv
peptid
peptidomimet
chikv
sfv
wnv
denv
influenza
ubiquit
presenc
furin
relat
pc
throughout
cell
bodi
make
proteas
vulner
exploit
virus
locat
furin
relat
pc
vesicl
constitut
protein
secret
pathway
virus
assembl
morphogenesi
disassembl
cell
entri
explain
divers
viru
type
evolutionarili
converg
depend
pc
virus
also
use
type
proteas
proteolyt
regul
bind
fusion
function
howev
proteas
restrict
specif
cell
type
limit
rang
viral
infect
virus
mutat
acquir
pc
reactiv
may
expand
cell
tropism
becom
pathogen
target
pc
inhibit
antivir
strategi
sound
possibl
probabl
major
advantag
approach
target
viral
compon
function
reduc
chanc
produc
resist
main
drawback
ubiquit
distribut
pc
potenti
toxic
secondari
effect
inhibit
may
caus
consequ
essenti
know
viru
pc
select
pc
inhibitor
select
one
two
pc
specif
group
furin
fund
research
receiv
extern
fund
author
declar
conflict
interest
